Department Directory

  • Carl Fichtenbaum, MD
  • Professor of Medicine
  • Academic Office:
    Medical Sciences Building
    Room6109
    Cincinnati, OH 45267
  • Clinical Office:
    Holmes Hospital
    200 Albert Sabin Way
    Cincinnati, OH 45229
  • Phone: 513-558-4704
  • Email: carl.fichtenbaum@uc.edu

    Research/Clinical Interests:

  • Internal Medicine, Infectious Dieases Research, HIV, Transplant Patients with Infections and Osteomyelitis

    Education/Credentials:

  • Bachelor's Degree: University of Missouri, 1983
  • Medical Degree: University of Missouri, 1985
  • Residency : Bridgeport Hospital , 1989
  • Residency : Bridgeport Hospital , 1990
  • Fellowship: Yale University School of Medicine , 1991
  • Fellowship: Barnes Hospital/Washington University School of Medicine, 1994
  • Fellowship: National Institute of Drug Abuse , 1994

Board Certifications & Licenses:

  • Diplomat, National Board of Medical Examiners, 1986
  • Diplomat, American Board of Internal Medicine, 1989
  • Voluntary Recertification, American Board of Internal Medicine, 2005
  • Diplomat, American Board of Pediatrics, 1989
  • Recertification, American Board of Pediatrics, 1996
  • Diplomat, American Board of Internal Medicine, Certification in Infectious Diseases, 1994
  • Recertification, American Board of Internal Medicine, Certification in Infectious Diseases, 2004
  • Ohio Medical License, State Medical Board of Ohio, 1999

Peer Reviewed Publications (in chronological order):

  • Warm, E. J., Mathis, B. R., Held, J. D., Pai, S., Tolentino, J., Ashbrook, L., Lee, C. K., Lee, D., Wood, S., Fichtenbaum, C. J., Schauer, D., Munyon, R., & Mueller, C. (2014). Entrustment and Mapping of Observable Practice Activities for Resident Assessment. . Journal of General Internal Medicine.
  • Wohl, D. A., Arnoczy, G., Fichtenbaum, C. J., Campbell, T., Taiwo, B., Hicks, C., McComsey, G. A., Koletar, S., Sax, P., Tebas, P., Ha, B., Massengale, K., Walsh, K., & Stein, J. H. (2013). Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. . Antiviral Therapy.
  • Lyons, M. S., Lindsell, C. J., Ruffner, A. H., Wayne, D. B., Hart, K. W., Sperling, M. I., Trott, A. T., & Fichtenbaum, C. J. (2013). Randomized Comparison of Universal and Targeted HIV Screening in the Emergency Department. . Journal of Acquired Immune Deficiency Syndromes (1999).
  • McComsey, G. A., Daar, E. S., O'Riordan, M., Collier, A. C., Kosmiski, L., Santana, J. L., Fichtenbaum, C. J., Fink, H., Sax, P. E., Libutti, D. E., & Gerschenson, M. (2013). Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202. . The Journal of Infectious Diseases , 207 (4) , 604-11.
  • Samineni, D., Desai, P. B., Sallans, L., & Fichtenbaum, C. J. (2012). Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin. . Journal of Clinical Pharmacology , 52 (6) , 922-31.
  • Presicce, P., Moreno-Fernandez, M. E., Rusie, L. K., Fichtenbaum, C., & Chougnet, C. A. (2012). In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells. . PloS One , 7 (8) , e42802.
  • Fichtenbaum, C. J., Evans, S. E., & Aberg, J. A. (2011). High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection. . AIDS (London, England) , 25 (16) , 2053.
  • Nyakeriga, A. M., Ying, J., Shire, N. J., Fichtenbaum, C. J., & Chougnet, C. A. (2011). Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo. . Viral Immunology , 24 (4) , 281-9.
  • Lyons, M. S., Lindsell, C. J., Wayne, D. B., Ruffner, A. H., Hart, K. W., Fichtenbaum, C. J., Trott, A. T., & Sullivan, P. S. (2011). Comparison of missed opportunities for earlier HIV diagnosis in 3 geographically proximate emergency departments. . Annals of Emergency Medicine , 58 (1 Suppl 1) , S17-22.e1.
  • Hudepohl, N. J., Lindsell, C. J., Hart, K. W., Ruffner, A. H., Trott, A. T., Fichtenbaum, C. J., & Lyons, M. S. (2011). Effect of an emergency department HIV testing program on the proportion of emergency department patients who have been tested. . Annals of Emergency Medicine , 58 (1 Suppl 1) , S140-4.
  • Sitlinger, A. P., Lindsell, C. J., Ruffner, A. H., Wayne, D. B., Hart, K. W., Trott, A. T., Fichtenbaum, C. J., & Lyons, M. S. (2011). Preliminary program evaluation of emergency department HIV prevention counseling. . Annals of Emergency Medicine , 58 (1 Suppl 1) , S120-5.e1-3.
  • Ubhayakar, N. D., Lindsell, C. J., Raab, D. L., Ruffner, A. H., Trott, A. T., Fichtenbaum, C. J., & Lyons, M. S. (2011). Risk, reasons for refusal, and impact of counseling on consent among ED patients declining HIV screening. . The American Journal of Emergency Medicine , 29 (4) , 367-72.
  • Fichtenbaum, Carl J (2011). Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. . Current Infectious Disease Reports , 13 (1) , 94-101.
  • Presicce, P., Orsborn, K., King, E., Pratt, J., Fichtenbaum, C. J., & Chougnet, C. A. (2011). Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. . PloS One , 6 (12) , e28118.
  • Taiwo, B., Zheng, L., Gallien, S., Matining, R. M., Kuritzkes, D. R., Wilson, C. C., Berzins, B. I., Acosta, E. P., Bastow, B., Kim, P. S., & Eron, J. J. (2011). Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262). . AIDS (London, England) , 25 (17) , 2113-22.
  • Sax, P. E., Tierney, C., Collier, A. C., Daar, E. S., Mollan, K., Budhathoki, C., Godfrey, C., Jahed, N. C., Myers, L., Katzenstein, D., Farajallah, A., Rooney, J. F., Ha, B., Woodward, W. C., Feinberg, J., Tashima, K., Murphy, R. L., & Fischl, M. A. (2011). Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. . The Journal of Infectious Diseases , 204 (8) , 1191-201.
  • Brehm, J. H., Lalama, C. M., Hughes, M. D., Haubrich, R., Riddler, S. A., Sluis-Cremer, N., & Mellors, J. W. (2011). Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. . Journal of Acquired Immune Deficiency Syndromes (1999) , 56 (4) , 344-8.
  • Samineni, D., & Fichtenbaum, C. J. (2010). (In Press). Fenofibrate in the treatment of dyslipidemia associated with HIV infection. . Expert Opinion on Drug Metabolism & Toxicology , 6 (8) , 995-1004.
  • Jacobson, J. M., Lalezari, J. P., Thompson, M. A., Fichtenbaum, C. J., Saag, M. S., Zingman, B. S., D'Ambrosio, P., Stambler, N., Rotshteyn, Y., Marozsan, A. J., Maddon, P. J., Morris, S. A., & Olson, W. C. (2010). (In Press). Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-infected Adults. . Antimicrobial Agents and Chemotherapy.
  • Fichtenbaum, Carl J (2010). (In Press). Does antiretroviral therapy increase or decrease the risk of cardiovascular disease? . Current HIV/AIDS Reports , 7 (2) , 92-8.
  • Murphy, R. L., Berzins, B., Zala, C., Fichtenbaum, C., Dube, M. P., Guaraldi, G., Torriani, F., Belsey, E., Mitchell, C., & Stein, J. H. (2010). (In Press). Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy. . AIDS (London, England) , 24 (6) , 885-90.
  • McComsey, G. A., Walker, U. A., Budhathoki, C. B., Su, Z., Currier, J. S., Kosmiski, L., Naini, L. G., Charles, S., Medvik, K., & Aberg, J. A. (2010). Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. . AIDS (London, England) , 24 (16) , 2507-15.
  • Flexner, C., Tierney, C., Gross, R., Andrade, A., Lalama, C., Eshleman, S. H., Aberg, J., Sanne, I., Parsons, T., Kashuba, A., Rosenkranz, S. L., Kmack, A., Ferguson, E., Dehlinger, M., & Mildvan, D. (2010). Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 50 (7) , 1041-52.
  • Lyons, M. S., Lindsell, C. J., Ruffner, A. H., Trott, A. T., & Fichtenbaum, C. J. (2009). (In Press). Relationship of self-reported prior testing history to undiagnosed HIV positivity and HIV risk. . Current HIV Research , 7 (6) , 580-8.
  • Nyakeriga, A. M., Fichtenbaum, C. J., Goebel, J., Nicolaou, S. A., Conforti, L., & Chougnet, C. A. (2009). (In Press). Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection. . Journal of Virology , 83 (3) , 1193-200.
  • Fichtenbaum, Carl J (2009). (In Press). Metabolic abnormalities associated with HIV infection and antiretroviral therapy. . Current Infectious Disease Reports , 11 (1) , 84-92.
  • Lyons, M. S., Lindsell, C. J., Raab, D. L., Ruffner, A. H., Trott, A. T., & Fichtenbaum, C. J. (2009). (In Press). Comparison of emergency department HIV testing data with visit or patient as the unit of analysis. . Journal of Medical Screening , 16 (1) , 29-32.
  • Gross, R., Tierney, C., Andrade, A., Lalama, C., Rosenkranz, S., Eshleman, S. H., Flanigan, T., Santana, J., Salomon, N., Reisler, R., Wiggins, I., Hogg, E., Flexner, C., & Mildvan, D. (2009). Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. . Archives of Internal Medicine , 169 (13) , 1224-32.
  • Haubrich, R. H., Riddler, S. A., DiRienzo, A. G., Komarow, L., Powderly, W. G., Klingman, K., Garren, K. W., Butcher, D. L., Rooney, J. F., Haas, D. W., Mellors, J. W., & Havlir, D. V. (2009). Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. . AIDS (London, England) , 23 (9) , 1109-18.
  • Stein, J. H., Komarow, L., Cotter, B. R., Currier, J. S., Dubé, M. P., Fichtenbaum, C. J., Gerschenson, M., Mitchell, C. K. C., Murphy, R. L., Squires, K., Parker, R. A., & Torriani, F. J. (2008). (In Press). Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. . Journal of Clinical Lipidology , 2 (6) , 464-471.
  • Jacobson, J. M., Saag, M. S., Thompson, M. A., Fischl, M. A., Liporace, R., Reichman, R. C., Redfield, R. R., Fichtenbaum, C. J., Zingman, B. S., Patel, M. C., Murga, J. D., Pemrick, S. M., D'Ambrosio, P., Michael, M., Kroger, H., Ly, H., Rotshteyn, Y., Buice, R., Morris, S. A., Stavola, J. J., Maddon, P. J., Kremer, A. B., & Olson, W. C. (2008). (In Press). Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults. . The Journal of Infectious Diseases , 198 (9) , 1345-52.
  • Torriani, F. J., Komarow, L., Parker, R. A., Cotter, B. R., Currier, J. S., Dubé, M. P., Fichtenbaum, C. J., Gerschenson, M., Mitchell, C. K. C., Murphy, R. L., Squires, K., & Stein, J. H. (2008). (In Press). Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. . Journal of the American College of Cardiology , 52 (7) , 569-76.
  • Dubé, M. P., Lipshultz, S. E., Fichtenbaum, C. J., Greenberg, R., Schecter, A. D., & Fisher, S. D. (2008). (In Press). Effects of HIV infection and antiretroviral therapy on the heart and vasculature. . Circulation , 118 (2) , e36-40.
  • Vazquez, J. A., Schranz, J. A., Clark, K., Goldstein, B. P., Reboli, A., & Fichtenbaum, C. (2008). (In Press). A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis. . Journal of Acquired Immune Deficiency Syndromes (1999) , 48 (3) , 304-9.
  • Lyons, M. S., Lindsell, C. J., R N, D. A. H., Rn, D. L. R., Trott, A. T., & Fichtenbaum, C. J. (2008). (In Press). Contributions to early HIV diagnosis among patients linked to care vary by testing venue. . BMC Public Health , 8 , 220.
  • Fichtenbaum, Carl J (2008). (In Press). Editorial comment: the head bone is connected to the body bone. . The AIDS Reader , 18 (5) , 265.
  • Gerber, J. G., Kitch, D. W., Fichtenbaum, C. J., Zackin, R. A., Charles, S., Hogg, E., Acosta, E. P., Connick, E., Wohl, D., Kojic, E. M., Benson, C. A., & Aberg, J. A. (2008). (In Press). Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. . Journal of Acquired Immune Deficiency Syndromes (1999) , 47 (4) , 459-66.
  • Velilla, P. A., Shata, M. T., Lages, C. S., Ying, J., Fichtenbaum, C. J., & Chougnet, C. (2008). (In Press). Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients. . AIDS Research and Human Retroviruses , 24 (1) , 52-61.
  • Riddler, S. A., Haubrich, R., DiRienzo, A. G., Peeples, L., Powderly, W. G., Klingman, K. L., Garren, K. W., George, T., Rooney, J. F., Brizz, B., Lalloo, U. G., Murphy, R. L., Swindells, S., Havlir, D., & Mellors, J. W. (2008). Class-sparing regimens for initial treatment of HIV-1 infection. . The New England Journal of Medicine , 358 (20) , 2095-106.
  • de Perio, M. A., Gomez, F. J., Frame, P. T., & Fichtenbaum, C. J. (2007). (In Press). A truvada hypersensitivity reaction simulating abacavir hypersensitivity. . AIDS (London, England) , 21 (16) , 2252-3.
  • Lyons, M. S., Raab, D. L., Lindsell, C. J., Trott, A. T., & Fichtenbaum, C. J. (2007). (In Press). A novel emergency department based prevention intervention program for people living with HIV: evaluation of early experiences. . BMC Health Services Research , 7 , 164.
  • Shire, N. J., Rouster, S. D., Stanford, S. D., Blackard, J. T., Martin, C. M., Fichtenbaum, C. J., & Sherman, K. E. (2007). (In Press). The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. . Journal of Acquired Immune Deficiency Syndromes (1999) , 44 (3) , 309-14.
  • Huang, I., Leach, J. L., Fichtenbaum, C. J., & Narayan, R. K. (2007). (In Press). Osteomyelitis of the skull in early-acquired syphilis: evaluation by MR imaging and CT. . AJNR. American Journal of Neuroradiology , 28 (2) , 307-8.
  • Wohl, D. A., McComsey, G., Tebas, P., Brown, T. T., Glesby, M. J., Reeds, D., Shikuma, C., Mulligan, K., Dube, M., Wininger, D., Huang, J., Revuelta, M., Currier, J., Swindells, S., Fichtenbaum, C., Basar, M., Tungsiripat, M., Meyer, W., Weihe, J., & Wanke, C. (2006). (In Press). Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 43 (5) , 645-53.
  • Robertson, J., Meier, M., Wall, J., Ying, J., & Fichtenbaum, C. J. (2006). (In Press). Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 42 (11) , 1639-46.
  • Aberg, J. A., Rosenkranz, S. L., Fichtenbaum, C. J., Alston, B. L., Brobst, S. W., Segal, Y., & Gerber, J. G. (2006). (In Press). Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108. . AIDS (London, England) , 20 (5) , 725-9.
  • Goldman, M., Cloud, G. A., Wade, K. D., Reboli, A. C., Fichtenbaum, C. J., Hafner, R., Sobel, J. D., Powderly, W. G., Patterson, T. F., Wheat, L. J., Stein, D. K., Dismukes, W. E., & Filler, S. G. (2005). (In Press). A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 41 (10) , 1473-80.
  • Aberg, J. A., Zackin, R. A., Brobst, S. W., Evans, S. R., Alston, B. L., Henry, W. K., Glesby, M. J., Torriani, F. J., Yang, Y., Owens, S. I., & Fichtenbaum, C. J. (2005). (In Press). A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. . AIDS Research and Human Retroviruses , 21 (9) , 757-67.
  • Glesby, M. J., Aberg, J. A., Kendall, M. A., Fichtenbaum, C. J., Hafner, R., Hall, S., Grosskopf, N., Zolopa, A. R., & Gerber, J. G. (2005). (In Press). Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. . Clinical Pharmacology and Therapeutics , 78 (2) , 143-53.
  • Gerber, J. G., Rosenkranz, S. L., Fichtenbaum, C. J., Vega, J. M., Yang, A., Alston, B. L., Brobst, S. W., Segal, Y., & Aberg, J. A. (2005). (In Press). Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. . Journal of Acquired Immune Deficiency Syndromes (1999) , 39 (3) , 307-12.
  • Glesby, M. J., Bassett, R., Alston-Smith, B., Fichtenbaum, C., Jacobson, E. L., Brass, C., Owens, S., Sulkowski, M., Race, E. M., & Sherman, K. E. (2005). (In Press). Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. . The Journal of Infectious Diseases , 191 (5) , 686-93.
  • Fichtenbaum, C. J., Hadigan, C. M., Kotler, D. P., Pierone, G., Sax, P. E., Steinhart, C. R., & Tebas, P. (2005). (In Press). Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care. . IAPAC Monthly , 11 (2) , 38-46.
  • Acosta, E. P., Wu, H., Hammer, S. M., Yu, S., Kuritzkes, D. R., Walawander, A., Eron, J. J., Fichtenbaum, C. J., Pettinelli, C., Neath, D., Ferguson, E., Saah, A. J., & Gerber, J. G. (2004). (In Press). Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals. . Journal of Acquired Immune Deficiency Syndromes (1999) , 37 (3) , 1358-66.
  • Goldman, M., Zackin, R., Fichtenbaum, C. J., Skiest, D. J., Koletar, S. L., Hafner, R., Wheat, L. J., Nyangweso, P. M., Yiannoutsos, C. T., Schnizlein-Bick, C. T., Owens, S., & Aberg, J. A. (2004). (In Press). Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 38 (10) , 1485-9.
  • Zhang, R., Fichtenbaum, C. J., Hildeman, D. A., Lifson, J. D., & Chougnet, C. (2004). (In Press). CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription. . Journal of Immunology (Baltimore, Md. : 1950) , 172 (4) , 2678-86.
  • Dubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D., & Glesby, M. J. (2003). (In Press). Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 37 (5) , 613-27.
  • Riddle, T. M., Fichtenbaum, C. J., & Hui, D. Y. (2003). (In Press). Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice. . Journal of Acquired Immune Deficiency Syndromes (1999) , 33 (5) , 564-70.
  • Fichtenbaum, Carl J (2003). (In Press). Antiretrovirals and cardiovascular disease: is HAART bad for your heart? . AIDS Clinical Care , 15 (8) , 69-73, 76.
  • Landon, B. E., Wilson, I. B., Cohn, S. E., Fichtenbaum, C. J., Wong, M. D., Wenger, N. S., Bozzette, S. A., Shapiro, M. F., & Cleary, P. D. (2003). (In Press). Physician specialization and antiretroviral therapy for HIV. . Journal of General Internal Medicine , 18 (4) , 233-41.
  • Levine, N. B., Kurokawa, R., Fichtenbaum, C. J., Howington, J. A., & Kuntz, C. (2002). (In Press). An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis. . Journal of Spinal Disorders & Techniques , 15 (5) , 425-30.
  • Daly, K. R., Fichtenbaum, C. J., Tanaka, R., Linke, M. J., O'Bert, R., Thullen, T. D., Hui, M. S., Smulian, A. G., & Walzer, P. D. (2002). (In Press). Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons. . The Journal of Infectious Diseases , 186 (5) , 644-51.
  • Riddle, T. M., Schildmeyer, N. M., Phan, C., Fichtenbaum, C. J., & Hui, D. Y. (2002). (In Press). The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice. . Journal of Lipid Research , 43 (9) , 1458-63.
  • Fichtenbaum, C. J., Gerber, J. G., Rosenkranz, S. L., Segal, Y., Aberg, J. A., Blaschke, T., Alston, B., Fang, F., Kosel, B., & Aweeka, F. (2002). (In Press). Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. . AIDS (London, England) , 16 (4) , 569-77.
  • David, M. H., Hornung, R., & Fichtenbaum, C. J. (2002). (In Press). Ischemic cardiovascular disease in persons with human immunodeficiency virus infection. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 34 (1) , 98-102.
  • Fichtenbaum, C. J., & Gerber, J. G. (2002). (In Press). Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection. . Clinical Pharmacokinetics , 41 (14) , 1195-211.
  • Landon, B. E., Wilson, I. B., Wenger, N. S., Cohn, S. E., Fichtenbaum, C. J., Bozzette, S. A., Shapiro, M. F., & Cleary, P. D. (2002). (In Press). Specialty training and specialization among physicians who treat HIV/AIDS in the United States. . Journal of General Internal Medicine , 17 (1) , 12-22.
  • Fichtenbaum, C J (2001). (In Press). The evaluation and management of dyslipidemia in HIV-infected patients. . AIDS Clinical Care , 13 (12) , 113-7, 120.
  • Riddle, T. M., Kuhel, D. G., Woollett, L. A., Fichtenbaum, C. J., & Hui, D. Y. (2001). (In Press). HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. . The Journal of Biological Chemistry , 276 (40) , 37514-9.
  • Soloway, B., & Fichtenbaum, C. J. (2001). (In Press). One size does not fit all. . AIDS Clinical Care , 13 (10) , 92-3.
  • Fichtenbaum, C. J., Zackin, R., & Feinberg, J. (2001). (In Press). Reply to 'Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis' by Holmberg and Moorman. . AIDS (London, England) , 15 (13) , 1745.
  • Currier, J. S., Williams, P., Feinberg, J., Becker, S., Owens, S., Fichtenbaum, C., & Benson, C. (2001). (In Press). Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 32 (11) , 1615-22.
  • Tantisiriwat, W., Tebas, P., Polish, L. B., Casabar, E., Powderly, W. G., & Fichtenbaum, C. J. (2001). (In Press). Elevated lactate levels in hospitalized persons with HIV infection. . AIDS Research and Human Retroviruses , 17 (3) , 195-201.
  • Riddle, T. M., Kuhel, D. G., Woollett, L. A., Fichtenbaum, C. J., & Hui, D. Y. (2001). HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. . The Journal of Biological Chemistry , 276 (40) , 37514-9.
  • Fichtenbaum, C. J., Zackin, R., Feinberg, J., Benson, C., & Griffiths, J. K. (2000). (In Press). Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. . AIDS (London, England) , 14 (18) , 2889-93.
  • Taylor, B. N., Fichtenbaum, C., Saavedra, M., Slavinsky III, J., Swoboda, R., Wozniak, K., Arribas, A., Powderly, W., & Fidel Jr, P. L. (2000). (In Press). In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. . The Journal of Infectious Diseases , 182 (3) , 955-9.
  • Fichtenbaum, C. J., Zackin, R., Rajicic, N., Powderly, W. G., Wheat, L. J., & Zingman, B. S. (2000). (In Press). Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295. . AIDS (London, England) , 14 (7) , 845-52.
  • Fichtenbaum, C. J., Koletar, S., Yiannoutsos, C., Holland, F., Pottage, J., Cohn, S. E., Walawander, A., Frame, P., Feinberg, J., Saag, M., Van der Horst, C., & Powderly, W. G. (2000). (In Press). Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 30 (5) , 749-56.
  • Fichtenbaum, C. J., German, M., Dunagan, W. C., Fraser, V. J., Medoff, G., Diego, J., & Powderly, W. G. (1999). (In Press). A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 29 (6) , 1551-6.
  • Tantisiriwat, W., Tebas, P., Clifford, D. B., Powderly, W. G., & Fichtenbaum, C. J. (1999). (In Press). Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 28 (5) , 1152-4.
  • Widmer, G., Tzipori, S., Fichtenbaum, C. J., & Griffiths, J. K. (1998). (In Press). Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. . The Journal of Infectious Diseases , 178 (3) , 834-40.
  • Fichtenbaum, C J (1998). (In Press). I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections. . Research Initiative, Treatment Action : RITA , 4 (4) , 3-7.
  • Cottler, L. B., Compton, W. M., Ben Abdallah, A., Cunningham-Williams, R., Abram, F., Fichtenbaum, C., & Dotson, W. (1998). (In Press). Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. . Public Health Reports (Washington, D.C. : 1974) , 113 Suppl 1 , 31-41.
  • Seydel, K. B., Zhang, T., Champion, G. A., Fichtenbaum, C., Swanson, P. E., Tzipori, S., Griffiths, J. K., & Stanley, S. L. (1998). (In Press). Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. . Infection and Immunity , 66 (5) , 2379-82.
  • Fichtenbaum, C. J., & Powderly, W. G. (1998). (In Press). Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 26 (3) , 556-65.
  • Wu, A. W., Jacobson, D. L., Berzon, R. A., Revicki, D. A., van der Horst, C., Fichtenbaum, C. J., Saag, M. S., Lynn, L., Hardy, D., & Feinberg, J. (1997). (In Press). The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. . Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation , 6 (1) , 3-10.
  • Fichtenbaum, C. J., Clifford, D. B., & Powderly, W. G. (1995). (In Press). Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association , 10 (2) , 169-74.
  • Arribas, J. R., Clifford, D. B., Fichtenbaum, C. J., Commins, D. L., Powderly, W. G., & Storch, G. A. (1995). (In Press). Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. . The Journal of Infectious Diseases , 172 (2) , 527-31.
  • Arribas, J. R., Clifford, D. B., Fichtenbaum, C. J., Roberts, R. L., Powderly, W. G., & Storch, G. A. (1995). (In Press). Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. . Journal of Clinical Microbiology , 33 (6) , 1580-3.
  • Fichtenbaum, C. J., Dunagan, W. C., & Powderly, W. G. (1995). (In Press). Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association , 8 (1) , 51-7.
  • Fichtenbaum, C. J., Woeltje, K. F., & Powderly, W. G. (1994). (In Press). Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 19 (3) , 417-22.
  • Fichtenbaum, C. J., Peterson, L. R., & Weil, G. J. (1993). (In Press). Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. . The American Journal of Medicine , 95 (4) , 351-7.
  • Fichtenbaum, C. J., Ritchie, D. J., & Powderly, W. G. (1993). (In Press). Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 16 (2) , 298-300.
  • Fichtenbaum, C. J., & Smith, M. J. (1992). (In Press). Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. . Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America , 14 (1) , 353-4.
  • Afridi, S. A., Fichtenbaum, C. J., & Taubin, H. (1991). (In Press). Review of duodenal diverticula. . The American Journal of Gastroenterology , 86 (8) , 935-8.
  • Fichtenbaum, C. J., Kleinman, G. M., & Haddad, R. G. (1990). (In Press). Eosinophilic granuloma of the lung presenting as a solitary pulmonary nodule. . Thorax , 45 (11) , 905-6.
  • Fichtenbaum, C. J., Babb, J. D., & Baker, D. A. (1988). (In Press). Erythromycin induced cardiovascular toxicity. . Connecticut Medicine , 52 (3) , 135-6.
  • Grandominico, J. M., & Fichtenbaum, C. J. (In Press). Short-term effect of HAART on blood pressure in HIV-infected individuals. . HIV Clinical Trials , 9 (1) , 52-60.
  • Lyons, M. S., Lindsell, C. J., Fichtenbaum, C. J., & Camargo, C. A. (In Press). Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings. . Public Health Reports (Washington, D.C. : 1974) , 122 (5) , 579-83.
  • Evans, S. R., Fichtenbaum, C. J., & Aberg, J. A. (In Press). Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087. . HIV Clinical Trials , 8 (1) , 45-52.
  • Fichtenbaum, Carl J (In Press). Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons. . HIV Clinical Trials , 5 (6) , 416-33.
  • Monteferrante, M. L., Shimkin, P. M., Fichtenbaum, C., Kleinman, G. M., & Lipow, K. I. (In Press). Tentorial traversal by ependymoblastoma. . AJNR. American Journal of Neuroradiology , 12 (1) , 181.
  • Mohajer, M. A., Lyons, M., King, E., Pratt, J., & Fichtenbaum, C. J. Internal Medicine and Emergency Medicine Physicians Lack Accurate Knowledge of Current CDC HIV Testing Recommendations and Infrequently Offer HIV Testing. . Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) , 11 (2) , 101-8.
  • Fichtenbaum, C. J., Yeh, T., Evans, S. R., & Aberg, J. A. Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087. . Journal of Clinical Lipidology , 4 (4) , 279-87.

    Research Grants:

  • 1 U01 AI069513 NIH/NIAID. AIDS Clinical Trials Group The major goals of this project are to design, conduct and analyze clinical trials to treat HIV disease and to treat/prevent its associated complications., PI, Active.
  • 1 T01 AI1068524 NIEHS. Role of Regulatory T Cells in HIV Infection To investigate the mechanisms of HIV control and risk of opportunistic infections in persons with HIV infection., Investigator, Active.
  • 5 H76HA0111 DHHS/HRSA. Cincinnati Health Network, Ryan White Title III Funds The major goal of this project is to provide care and services to persons with and at risk for HIV infection., Co-PI, Active.
  • 5 U01 NS032228-12 National Institute of Neurological Disorders & Stroke Washington University. Neurological AIDS Research Consortium A randomized strategy study for HIV-1 infected treatment experienced subjects using the cPSS to select an effective regimen., Investigator, Active.
  • 1 R56A1087462-01A1 NIH/NIAID. Transmission Network Targeting Adjunct to Emergency Department Screening A pilot study of testing more persons for HIV and linking them to care in different locations including the emergency department, Health Department and an HIV treatment center., Investigator, Active.
  • U10 DA013732 NIDA. Clinical Trials Network Ohio Valley Node Network of unites to conduct clinical trials in substance abusers. Dr. Fichtenbaum serves on steering committee and HIV special interest group., Investigator, Active.
  • 000059 Health Resources and Services Administration. Community HIV comprehensive Care Program, PI, Closed.
  • CHMC 103666 National Institute of Allergy and Infectious Diseases. Role of Regulatory T Cells in HIV Infection, PI, Closed.
  • Research Triangle Institute. RTI AIDS/Cancer Cohort Study, PI, Closed.
  • CHMC 430 / R01 AI056927 National Institute of Allergy and Infectious Diseases. CD40 Ligand Dysregulation and HIV Pathogenesis, PI, Closed.
  • 7-R01-DA-09825-04-A0-S0-E0 National Institute on Drug Abuse. Epidemiology and Outcome of STDS in Drug Users, PI, Closed.
  • SRS 004193 Bristol-Myers Squibb Co.. Lower HDL and Elevated Triglycerides Predict HIV-Associated Lipoatrophy, PI, Closed.
  • BRS-ACURE-Q-06-0000164 (Master Agreement) / U01 AI068636 National Institute of Allergy and Infectious Diseases. AIDS Clinical Trials Group Network, PI, Closed.
  • CRB-DCR01-S-09-00319 / HHSN272200900001/2/3I National Institute of Allergy and Infectious Diseases. SSS Master Agreement, PI, Active.
  • CRB-UCLA-S-10-00045 / R01 HL095132 National Heart, Lung and Blood Institute. Cardiovascular, Anthropometric, and Skeletal Effects of Anti-Retroviral Initiation with Tenofovir/Emtricitabine plus Atazanavir/Ritonavir, Darunavir/Ritonavir or Raltegravir, PI, Active.
  • WU-10-197 National Institute of Neurological Disorders and Stroke. Neurologic AIDS Research Consortium - Washington University Sub, PI, Closed.
  • CRB-UWAS1-S-11-0027 / HL095126 National Heart, Lung and Blood Institute. Carotid Artery Intima Media Thickness and Brachial Artery Imaging, PI, Active.
  • BRS-ACURE-S-12-002363 Aids Clinical Trials Group Network. A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maravirco-Containing, PI, Active.
  • BRS-ACURE-S-12-00214 Bristol-Myers Squibb Co.. A Prospective Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART), PI, Active.
  • BRS-ACURE-S-12-000604-002301 National Institute of Allergy and Infectious Diseases. AIDS Clinical Trials Group Network, PI, Closed.
  • CHN Sub \ H76HAO0111 Health Resources and Services Administration. Community HIV Comprehensive Care Program, Collaborator, Active.
  • CRB-SSS-S-12-00296 Merck Sharp & Dohme Corp. Aids Clinical Trial Group -A5309 - Patient Remunerations, PI, Active.
  • 108364 National Institute of Allergy and Infectious Diseases. ACTG PIF Year 6 Supplement, PI, Awarded.
  • UC-2013-01/HHSN272201300013I National Institute of Allergy and Infectious Diseases. Sexually Transmitted Infections Clinical Trials Group (STI-CTG) , PI, Awarded.
  • RES508646 / UM1 AI069501 National Institute of Allergy and Infectious Diseases. AIDS Clinical Trial Group , PI, Awarded.
  • 110208 / UM1AI068636 National Institute of Allergy and Infectious Diseases. ACTG Protocol Funds, PI, Awarded.
  • 110406 Gilead Sciences, Inc.. Long Term Effects of ARV Therapy on Change in the Bone Mineral Denisty in Infected Subjects , PI, Active.
  • 224838 / U01 HL123336 National Heart, Lung and Blood Institute. Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), PI, Active.

Recent Awards/Honors:

  • . Peterson, LR and Fichten baum, CJ. Human Ehrlichiosis presenting as a life-threatening illness. First prize, American College of Physicians Associates Clinical Research Competition. ACP Spring Meeting, Washington DC, 1993
  • Trainee, National Institute of Drug Abuse, Washington University, 1992,1994
  • John T. Carey Young Investigator Award, Adult AIDS Clinical Trials Group, 1996
  • Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Second Edition, 2005
  • Top Doctors Award in Infectious Diseases, Cincinnati Magazine, 2005
  • Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Third Edition, 2006
  • Top Doctors Award in Infectious Diseases, Cincinnati Magazine, 2006
  • Health Care Heroes, Winner, Cincinnati Business Courier, 2007
  • Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Fourth Edition, 2007
  • Top Doctors Award in Infectious Diseases, Cincinnati Magazine, 2007
  • . First Prize, Research Poster Competition. Bobula SM, Fichtenbaum CJ. Mismanagement of HIV-1 Infected Adults with Acute Febrile Illnesses by Cd4+ Count Risk Stratification. Ohio ACP Chapter Meeting, 2007
  • Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Fifth Edition, 2008
  • Top Doctors Award in Infectious Diseases, Cincinnati Magazine, 2008
  • Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Sixth Edition, 2009
  • Top Doctors Award in Infectious Diseases, Cincinnati Magazine, 2009
CARE/Crawley Building

More Information


For more information on the UC Department of Internal Medicine, please contact us at:

UC Department of Internal Medicine
231 Albert Sabin Way
Medical Sciences Building Room 6065
PO Box 670557
Cincinnati, OH 45267-0557

Phone: 513-558-4231
Fax: 513-558-0852
Email: ucintmed@uc.edu